Precision Medicine for Retinal Disease

Vinit Mahajan is Associate Professor, vitreoretinal surgeon and scientist in the Department of Ophthalmology at Stanford University. He directs the NIH-funded Omics Laboratory that uses high-throughput methods in genomics, proteomics, and phenomics to identify molecules involved in vitreoretinal disease. His research team discovered the first gene to cause non syndromic uveitis and is now using protein crystallography to design therapeutic inhibitors for calpain-5. Prof Mahajan and his team also performed the first CRISPR gene editing therapy for eye disease in human stem cells.